Transport of anti-allergic drugs across the passage cultured human ...

210 H. Lin et al. / European Journal of Pharmaceutical Sciences 26 (2005) 203–210Bremer, S., Hoof, T., Wilke, M., Busche, R., Scholte, B., Riordan,J.R., Maass, G., Tummler, B., 1992. Quantitative expression patternsof multidrug-resistance P-glycoprotein (MDR1) and differentiallyspliced cystic-fibrosis transmembrane-conductance regulator mRNAtranscripts in human epithelia. Eur. J. Biochem. 206, 137–149.Buchanan, J.A., Yeger, H., Tabcharani, J.A., Jensen, T.J., Auerbach, W.,Hanrahan, J.W., Riodan, J.R., Buchwald, M., 1990. Transformed sweatgland and nasal epithelial cell lines from control and cystic fibrosisindividuals. J. Cell Sci. 95 (Pt. 1), 109–123.Dearden, J.C., Bresnen, G.M., 1988. The measurement of partition coefficients.Quant. Struct. Act. Relat. 7, 133–144.Elbert, K.J., Schafer, U.F., Schafers, H.J., Kim, K.J., Lee, V.H., Lehr,C.M., 1999. Monolayers of human alveolar epithelial cells in primaryculture for pulmonary absorption and transport studies. Pharm. Res.16, 601–608.Freshney, R.I., 1994. Chapter of Media. Culture of Animal Cells: A Manualof Basic Technique, fourth Wiley-Liss Inc, pp. 99.Henriksson, G., Norlander, T., Zheng, X., Stierna, P., Westrin, K.M., 1997.Expression of p-glycoprotein 170 in nasal mucosa may be increasedwith topical steroids. Am. J. Rhinol. 11, 317–321.Huang, C.H., Kimura, R., Nassar, R.B., Hussain, A., 1985. Mechanism ofnasal absorption of drugs. Part I: physicochemical parameters influencingthe rate of in situ nasal absorption of drugs in rats. J. Pharm.Sci. 74, 608–611.Hussain, A.A., Hirai, S., Bawarshi, R., 1981. Nasal absorption of naturalcontraceptive steroids in rats: progesterone absorption. J. Pharm. Sci.70, 466–467.Jorissen, M., Bessems, A., 1995. Influence of culture duration and ciliogenesison the relationship between ciliary beat frequency andtemperature in nasal epithelial cells. Eur. Arch. Otorhinolaryngol. 252,451–454.Kissel, T., Werner, U., 1998. Nasal delivery of peptides: an in vitro cellculture model for the investigation of transport and metabolism inhuman nasal epithelium. J. Control. Release 53, 195–203.Krishnamoorthy, R., Mitra, A.K., 1998. Prodrugs for nasal drug delivery.Adv. Drug Deliv. Rev. 29, 135–146.Lipworth, B.J., Jackson, C.M., 2000. Safety of inhaled and intranasalcorticosteroids: lessons for the new millennium. Drug Saf. 23, 11–33.Mathias, N.R., Kim, K.J., Robison, T.W., Lee, V.H., 1995. Developmentand characterization of rabbit tracheal epithelial cell monolayer modelsfor drug transport studies. Pharm. Res. 12, 1499–1505.Morimoto, K., Yamaguchi, H., Iwakura, Y., Miyazaki, M., Nakatani,E., Iwamoto, T., Ohashi, Y., Nakai, Y., 1991. Effects of proteolyticenzyme inhibitors on the nasal absorption of vasopressin and an analogue.Pharm. Res. 8, 1175–1179.Osth, K., Grasjo, J., Bjork, E., 2002. A new method for drug-transportstudies on pig nasal mucosa using a horizontal Ussing chamber. J.Pharm. Sci. 91, 1259–1273.Perloff, M.D., von Moltke, L.L., Greenblatt, D.J., 2002. Fexofenadinetransport in Caco-2 cells: inhibition with verapamil and ritonavir. J.Clin. Pharmacol. 42, 1269–1274.Roh, H.J., Goh, E.K., Wang, S.G., Chon, K.M., Yoon, J.H., Kim, Y.S.,1999. Serially passaged normal human nasal epithelial cells: morphologyand mucous secretory differentiation. Korean J. Rhinol. 6,107–112.Ruckes, C., Blank, U., Moller, K., Rieboldt, J., Lindemann, H., Munker,G., Clauss, W., Weber, W.M., 1997. Amiloride-sensitive Na+ channelsin human nasal epithelium are different from classical epithelial Na+channels. Biochem. Biophys. Res. Commun. 237, 488–491.Saha, P., Kim, K.J., Yamahara, H., Crandall, E.D., Lee, V.H.L., 1994.Influence of lipophilicity on -blocker permeation across rat alveolarepithelial cell monolayers. J. Control. Release 32, 191–200.Schmidt, M.C., Peter, H., Lang, S.R., Ditzinger, G., Merkle, H.P., 1998. Invitro cell models to study nasal mucosal permeability and metabolism.Adv. Drug Deliv. Rev. 29, 51–79.Wadell, C., Bjork, E., Camber, O., 2003. Permeability of porcine nasalmucosa correlated with human nasal absorption. Eur. J. Pharm. Sci.18, 47–53.Wang, W., Sasaki, H., Chien, D.S., Lee, V.H., 1991. Lipophilicity influenceon conjunctival drug penetration in the pigmented rabbit: acomparison with corneal penetration. Curr. Eye Res. 10, 571–579.Werner, U., Kissel, T., 1995. Development of a human nasal epithelialcell culture model and its suitability for transport and metabolismstudies under in vitro conditions. Pharm. Res. 12, 565–571.Wioland, M.A., Fleury-Feith, J., Corlieu, P., Commo, F., Monceaux, G.,Lacau-St-Guily, J., Bernaudin, J.F., 2000. CFTR, MDR1, and MRP1immunolocalization in normal human nasal respiratory mucosa. J. Histochem.Cytochem. 48, 1215–1222.Yang, J.J., Ueda, H., Kim, K., Lee, V.H., 2000. Meeting future challengesin topical ocular drug delivery: development of an air-interfaced primaryculture of rabbit conjunctival epithelial cells on a permeablesupport for drug transport studies. J. Control. Release 65, 1–11.Yoo, J.W., Kim, Y.S., Lee, S.H., Lee, M.K., Roh, H.J., Jhun, B.H.,Lee, C.H., Kim, D.D., 2003. Serially passaged human nasal epithelialcell monolayer for in vitro drug transport studies. Pharm. Res. 20,1690–1696.